SCHEMBL7985446

SCHEMBL7985446

Oc1nc(-c2ccccc2F)nc2ncn(CCCOc3ccccc3)c12

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GBA1 P04062 1/20 0.41
SMN1; SMN2 Q16637 5/20 0.39
LMNA P02545 4/20 0.39
ALOX15 P16050 1/20 0.39
TSHR P16473 1/20 0.39
MAPK14 Q16539 2/20 0.39
MAPK13 O15264 1/20 0.39
MAPK12 P53778 1/20 0.39
MAPK11 Q15759 1/20 0.39
MAPT P10636 2/20 0.37
RAB9A P51151 2/20 0.37
TP53 P04637 3/20 0.36
HTT P42858 2/20 0.36
CNOT7 Q9UIV1 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
NPC1 O15118 1/20 0.34
MCL1 Q07820 1/20 0.34
CPT2 P23786 1/20 0.34
CPT1A P50416 1/20 0.34
GRM5 P41594 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7984482 0.94 GBA1 (0.42) GBA1SMN1; SMN2LMNAALOX15TSHR
SCHEMBL7984465 0.86 CNOT7 (0.41) LMNATSHRMAPK14MAPTCNOT7
SCHEMBL7974276 0.83 HTT (0.39) MAPK14MAPTHTTCNOT7ALDH1A1
SCHEMBL7974646 0.81 MAPK14 (0.47) SMN1; SMN2TSHRMAPK14MAPTCNOT7
SCHEMBL7973917 0.78 LMNA (0.40) LMNAMAPK14MAPTTP53ALDH1A1
SCHEMBL7985536 0.77 SMN1; SMN2 (0.42) SMN1; SMN2LMNAALOX15TSHRMAPK14
SCHEMBL7985444 0.77 CNOT7 (0.41) SMN1; SMN2LMNAALOX15TSHRMAPK14
SCHEMBL7988184 0.76 MET (0.42) SMN1; SMN2LMNATSHRMAPK14MAPT
SCHEMBL7985870 0.76 GAA (0.50) TSHRMAPK14TP53L3MBTL1ALDH1A1
SCHEMBL7974060 0.75 SMN1; SMN2 (0.41) SMN1; SMN2LMNAMAPK14RAB9AHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6310070-B1 FOR TREATING NEPHRITIS, IMPROVING PROTEINURIA DUE TO GLOMERULONEPHRITIS AND PREVENTING AGGRAVATION OF NEPHRITIS JAPAN ENERGY CORPORATION (JP) 2001-10-30 US disclosed
EP-0999211-A1 NOVEL PURINE DERIVATIVES AND MEDICINAL USE THEREOF JAPAN ENERGY CORPORATION (JP) 2000-05-10 EP disclosed